Global $50+ Bn Pain Management Drugs and Devices Markets to 2022

DUBLIN, September 20, 2017 /PRNewswire/ --

The "The Global Market for Pain Management Drugs and Devices" report has been added to Research and Markets' offering.

The Global Market for Pain Management will Grow from Nearly $36.1 Billion in 2017 to $52.0 Billion by 2022, with a CAGR of 7.6% for the Period of 2017-2022

This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

Report Includes

• An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
• Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Examination of product categories, use of products, and the competitive landscape
• Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
• Discussion of new regulatory requirements
• Comprehensive company profiles of major players in the industry
  

The report identifies two general segments of pain management:

• Pharmaceuticals.
• Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

• Narcotic pain management.
• Non-narcotic pain management.
• Antimigraine treatments.
• Anesthetics.
• Other drugs (including CNS therapies).

The device segment covers several product lines and specifically targets the largest product segments including:

• Electrotherapy stimulators.
• Spine stimulators.
• Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.

A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:

Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.